Leveraging Home Health Aides to Improve Outcomes in Heart Failure
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04239911 |
Recruitment Status :
Recruiting
First Posted : January 27, 2020
Last Update Posted : June 29, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Heart Failure Congestive Heart Failure | Behavioral: mHealth app Behavioral: Virtual training course | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 104 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | 104 home health aides will be recruited from VNSNY and randomized to either enhanced usual care arm (heart failure training course; n = 52) or the intervention (heart failure training course plus mHealth app; n =52). Four nurses will also be recruited to the study. The total duration of each home health aides' involvement will be 90 days. |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Data analyst will be blinded to study arm. |
Primary Purpose: | Health Services Research |
Official Title: | Leveraging Home Health Aides to Improve Outcomes in Heart Failure: A Pilot Randomized Controlled Trial |
Actual Study Start Date : | May 16, 2022 |
Estimated Primary Completion Date : | October 2023 |
Estimated Study Completion Date : | December 2023 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Enhanced usual care
Home health aides in the enhanced usual care arm will receive a virtual heart failure training course.
|
Behavioral: Virtual training course
Virtual training course on heart failure for home health aides. |
Experimental: Intervention arm
Home health aides in the intervention arm will receive a virtual heart failure training course and a communication-based messaging app.
|
Behavioral: mHealth app
The mHealth app will provide heart failure-specific education to home health aides and allow them to report clinical observations and ask nurses questions in real-time. Behavioral: Virtual training course Virtual training course on heart failure for home health aides. |
- Change in Heart Failure Knowledge [ Time Frame: Baseline (0 days); at follow-up (90 days) ]As measured by the Dutch Heart Failure Knowledge Scale, scores range from 0-15; higher scores indicate greater heart failure knowledge.
- Change in Heart Failure Caregiving Self-efficacy [ Time Frame: Baseline (0 days); at follow-up (90 days) ]As measured by the Caregiver Contribution to Self-Care in Heart Failure Index, which is a 22-item scale which assesses maintenance, management, and self-efficacy sub-scales separately. Each sub-scale score ranges from 0-100, with greater scores indicating greater contribution to care or self-efficacy. Scores < 70 are considered poor or inadequate.
- Change in Job Satisfaction [ Time Frame: Baseline (0 days); at follow-up (90 days) ]As measured by the Work Domain Satisfaction Scale, which is a 5-item scale that measures: 1) job satisfaction among care workers; and 2) examines the associations with work environment factors, work stressors, and health issues. Scores range from 5-20, with higher scores indicating stronger satisfaction.
- Change in Intention to Leave [ Time Frame: Baseline (0 days); at follow-up (90 days) ]As measured by the Turnover Intention Scale, which is a 2-item scale that measures workers' intentions of 1) leaving their current job (at their agency) and 2) searching for a new job (in another field) in the next year.
- Number of visits to the emergency department [ Time Frame: 90 days ]All-cause emergency department visits to any emergency department
- Number of readmissions to the hospital [ Time Frame: 90 days ]All-cause readmissions to any hospital

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 75 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Home health aide employed at VNSNY's Partners in Care home care agency.
- 1 or more years of experience as a home health aide.
- Speak English or Spanish.
- Assigned to care for an adult admitted to home care with a primary diagnosis of heart failure.
Exclusion Criteria:
- Doesn't meet inclusion criteria.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04239911
Contact: Madeline R Sterling, MD, MPH, MS | 6469625029 | mrs9012@med.cornell.edu |
United States, New York | |
Visiting Nurse Service of New York's Partners in Care | Recruiting |
New York, New York, United States, 10017 | |
Contact: Margaret McDonald, MSW margaret.mcdonald@vnsny.org | |
Contact: Penny H Feldman, PhD 2126091530 pfeldman@vnsny.org | |
Principal Investigator: Penny H Feldman, PhD |
Principal Investigator: | Madeline R Sterling, MD, MPH, MS | Weill Medical College of Cornell University |
Responsible Party: | Weill Medical College of Cornell University |
ClinicalTrials.gov Identifier: | NCT04239911 |
Other Study ID Numbers: |
19-08020553 K23HL150160-01 ( U.S. NIH Grant/Contract ) |
First Posted: | January 27, 2020 Key Record Dates |
Last Update Posted: | June 29, 2022 |
Last Verified: | June 2022 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
home health aides home health care home care agency |
Heart Failure Heart Diseases Cardiovascular Diseases |